An open-label, prospective, large-scale trial was carried out to evaluate the benefits of coating these balloons with sirolimus, which is an antiproliferative drug. The trial followed ...

(CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world's largest randomised controlled trial of a Sirolimus-coated ...

Concept Medical Inc. announced the presentation of primary results of the SirPAD randomized controlled trial of the company’ ...

Angioplasty with sirolimus-coated balloons, as compared with uncoated balloons, reduced limb amputation and other adverse ...

MicroPort NeuroScientific Corporation announced that the company’s Apollo Dream sirolimus target-eluting stent system has b ...

Hyperinsulinemic hypoglycemia is the most common cause of severe, persistent neonatal hypoglycemia. The treatment of hyperinsulinemic hypoglycemia that is unresponsive to diazoxide is subtotal ...

For femoropopliteal and BTK patients, the sirolimus balloon was associated with fewer limb events at 1 year than POBA.

The two medications can be administered concomitantly if various factors are taken into account. CHICAGO—Clinicians can safely use sirolimus and voriconazole concurrently if certain steps are followed ...

Please provide your email address to receive an email when new articles are posted on . Four of six patients who used sirolimus had positive responses and discontinued systemic corticosteroids. Three ...

Background: Sirolimus-eluting stents have recently been shown to reduce the risk of restenosis among patients who undergo percutaneous coronary intervention (PCI). Given that sirolimus-eluting stents ...

Acute GVHD (aGVHD) is a major cause of morbidity and mortality in hematopoietic allograft recipients. The best therapy for patients failing to respond, or not tolerating, systemic glucocorticoids ...

Newark, May 22, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 250 million in 2023 global sirolimus market will reach USD 370.06 million in 2033. Sirolimus is also known as ...